Herald Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200,000
Closed -$3.14M 109
2022
Q2
$3.14M Hold
200,000
0.73% 42
2022
Q1
$3.04M Hold
200,000
0.55% 57
2021
Q4
$3.07M Hold
200,000
0.5% 58
2021
Q3
$1.74M Hold
200,000
0.29% 79
2021
Q2
$2.04M Hold
200,000
0.33% 74
2021
Q1
$2.39M Hold
200,000
0.42% 68
2020
Q4
$1.82M Buy
200,000
+60,000
+43% +$464K 0.32% 72
2020
Q3
$852K Hold
140,000
0.18% 86
2020
Q2
$1.24M Hold
140,000
0.29% 74
2020
Q1
$1.01M Hold
140,000
0.31% 70
2019
Q4
$1.23M Hold
140,000
0.31% 68
2019
Q3
$852K Hold
140,000
0.25% 71
2019
Q2
$583K Hold
140,000
0.16% 83
2019
Q1
$880K Hold
140,000
0.22% 74
2018
Q4
$907K Hold
140,000
0.29% 68
2018
Q3
$1.16M Hold
140,000
0.3% 62
2018
Q2
$872K Hold
140,000
0.24% 72
2018
Q1
$959K Hold
140,000
0.29% 65
2017
Q4
$922K Hold
140,000
0.29% 66
2017
Q3
$778K Hold
140,000
0.25% 69
2017
Q2
$1.08M Hold
140,000
0.37% 61
2017
Q1
$1.26M Hold
140,000
0.46% 56
2016
Q4
$1.51M Buy
140,000
+40,000
+40% +$533K 0.65% 42
2016
Q3
$1.63M Hold
100,000
0.61% 49
2016
Q2
$953K Buy
+100,000
New +$1.09M 0.4% 58

Other funds holding NPTN

Herald Investment Management's NPTN Position: Q3 2022 in Review

Herald Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 200,000 shares — an estimated $3.14M sold.

Herald Investment Management first reported a position in NPTN in Q2 2016 and held it in 25 quarters. The position peaked at $3.14M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Herald Investment Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Herald Investment Management sold 200,000 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3.14M.
  • Herald Investment Management first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 25 quarters.
  • Herald Investment Management's NEOPHOTONICS CORP position peaked at $3.14M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Herald Investment Management's 13F filing for Q3 2022, filed 7 Nov 2022.